Gene therapy for knee pain: does it last?
Disease control
ENROLLING_BY_INVITATION
This study follows 16 people who previously received ICM-203 (a gene therapy) or a placebo for knee osteoarthritis. Researchers will track delayed side effects and measure changes in knee pain and function over time. The goal is to understand the long-term safety and effectivenes…
Sponsor: ICM Co. Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC